2024. miR-149-3p targeting TMPRSS4 regulates the sensitivity to cisplatin to inhibit the progression of lung cancer. Biomolecules and Biomedicine. 25, 1 (Dec. 2024), 165–176. DOI:https://doi.org/10.17305/bb.2024.11163.